bevacizumab,atezolizumab,cisplatin,pembrolizumab
roche,merck
['atezo', 'imbrave050', 'hcc']
imbrave050 phiii adj atezo/bev up to 1 yr vs. surveillance in resected/ablated #hcc high risk of recur (vasc inv, tumor &gt;5 cm, &gt;3 tumors, g3-4 path) w/median 17.4 mo f/u rfs hr 0.72 in favor of adj #io w/o clin meaningful deterioration in hrqol across arms #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope